Dr. Alex de Giorgio
Co-Founder & CEO
Prior to founding Sable, Alex worked at BenevolentAI, leading multiple disease deployments, pioneering new methods for relationship extraction, and building and launching a drug repositioning platform.
He holds a BSc in Biology from the University of Oxford and a PhD from Imperial College, with his publications gaining over 1000 citations.
